+49 170 62 47 020
Jörg Kotzerke

Professor

Jörg Kotzerke

Nuclear Medicine Radiologist

University Hospital Dresden

About the doctor

Profile

Radioembolization of liver metastases using radioactive holmium — a pioneering, image-guided therapy for unresectable hepatic tumors, scintigraphy of the thyroid gland, gastrointestinal tract, liver, and kidneys, radioiodine therapy for both benign thyroid disorders (e.g., hyperthyroidism, toxic nodules) and differentiated thyroid cancer, radioimmunotherapy (RIT) for malignant lymphomas, selective Internal Radiation Therapy (SIRT) for primary and metastatic liver tumors

Work experience

41 years

Scientific activity

Author of over 370 peer-reviewed scientific publications in nuclear medicine, molecular imaging, and targeted radionuclide therapy

Led the first German clinical team to implement holmium-based radioembolization for liver cancer a precision theranostic approach now used internationally

We treat every patient according to the latest scientific and technological advances—always with humanity, responsibility, and individualized care.

Jörg Kotzerke

Data

Director, Department of Nuclear Medicine, University Hospital Carl Gustav Carus Dresden

Professor of Nuclear Medicine, Faculty of Medicine, Technische Universität Dresden (since 2002)

Recognized as one of Germany’s leading experts in theranostics, radioiodine therapy, and liver-directed radionuclide treatments

Community

German Society of Nuclear Medicine (DGN)

German Radiological Society (DRG)

European Association of Nuclear Medicine (EANM)

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

German Cancer Society (DKG)

Fill out an application